profit from every $100 of sales.
$0$100
GoHealth
We have no price for GoHealth since 28 July 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$0.34+0.00% today
-92.3% since Oct 13, 25
1-year low $0.291-year high $4.52
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
Not measured for banks and insurers: deposits and policy reserves count as debt, so the usual debt test says nothing about them.
Money in, money out
What GoHealth sold, what it kept, and what it did with the cash.
Sales went from $632 million in 2022 to $362 million in 2025, with -$257 million of profit last year.
SalesProfit
GoHealth vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| GoHealth | No profit yet | ||
 Willis Towers Watson Public | 19.3× · Fair price | ||
 Brown & Brown | 22.6× · Fair price | ||
 Erie Indemnity | 25.7× · Fair price | ||
 The Baldwin Insurance Group | No profit yet |
AI analysis
An AI analyst reads GoHealth's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 632 | 735 | 799 | 362 | |
| 444 | 576 | 668 | 266 | |
| -281 | -69 | -7 | -153 | |
| -212 | 24 | 174 | -334 | |
| -149 | -63 | -3 | -257 | |
| -17.72 | -7.19 | -0.66 | -20.17 | |
| 70.3% | 78.4% | 83.7% | 73.4% | |
| -44.5% | -9.4% | -0.9% | -42.3% | |
| -23.5% | -8.6% | -0.4% | -71.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,659 | 1,500 | 1,488 | 987 |
| Cash | 16 | 91 | 41 | 33 |
| Total debt | 557 | 543 | 528 | 673 |
| Total liabilities | 1,068 | 1,045 | 1,030 | 993 |
| 318 | 280 | 295 | 95 | |
| 8 | 9 | 10 | 13 | |
| -28.7% | -7.8% | 6.5% | -42.6% | |
| -46.8% | -22.6% | -1.0% | -271.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 61 | 109 | -22 | -122 | |
| 14 | 14 | 14 | 8 | |
| 47 | 95 | -35 | -130 | |
| Dividends paid | 0 | 4 | 0 | 0 |
| 0 | 2 | 2 | 5 | |
| 27 | 20 | 11 | 9 |
This is a bank or insurer, so cash-flow and debt ratios are left out: borrowing and lending is the business itself. Price to book and return on equity are the measures that matter here.
Valuation
- –
- –
- –
- –
- 0.0×
- -2,877.0%
- 0.0%
Profitability
- -71.1%
- –
- –
- –
- –
Growth
- −16.9%
- –
- –
- –
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 5%of 522
Bottom 8%of 911
What analysts expect
- Average price target
- $5.00
- Range
- $5.00 – $5.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 18, 2026 | -2.36 | -2.40 | +1.7% |
| Mar 31, 2026 | -1.03 | -2.69 | +61.7% |
| Nov 13, 2025 | -0.19 | -2.06 | +90.8% |
| Aug 7, 2025 | -1.23 | -2.60 | +52.7% |
| May 13, 2025 | -0.47 | -0.26 | −80.8% |
| Feb 27, 2025 | 2.41 | 1.16 | +107.8% |
| Nov 7, 2024 | -3.73 | -3.19 | −16.9% |
| Aug 8, 2024 | -0.75 | -2.47 | +69.6% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
36No pass
Philip Fisher
43No pass
Peter Lynch
31No pass
Joel Greenblatt
2No pass
Charlie Munger
35No pass
Terry Smith
23No pass
Questions about GoHealth
Is GoHealth a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the GoHealth AI analysis
What does GoHealth do?
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. It is in Insurance - Brokers.
Does GoHealth pay a dividend?
No. GoHealth does not pay a dividend at the moment; in 2025 it returned $5.22 million to shareholders by buying back its own shares.
Is GoHealth stock halal?
Questionable. GoHealth sits in a grey zone: scholars disagree about its industry. How we check
Who are GoHealth's competitors?
The largest listed companies in the same industry are Willis Towers Watson Public, Brown & Brown, Erie Indemnity and The Baldwin Insurance Group. The peers table on this page compares their profit, growth and price with GoHealth's.
Prices: daily closes to Jul 28, 2026. Fundamentals: company reports via invest-like data.